INDP ALUMNI 2014

INDP 2014

Pietro Vertechi (Italy) - Mainen Lab
Thabelo Khoboko (Lesotho) - IMM / Mainen Lab 
Tomás Cruz (Portugal) - Chiappe Lab    
Bruno Cruz (Portugal) - Paton Lab    
Miguel Gaspar (Portugal) - Vasconcelos Lab    
Francisco Romero (Spain) - Polavieja Lab
Tatiana Silva (Portugal) - Carey Lab
Inês Vaz (Portugal) - Costa Lab

INCDP Alumni 2014

 

INDP ALUMNI 2013

INDP 2013

Antonia Groneberg (Germany) - Orger Lab 
Madalena Fonseca (Portugal) - Mainen Lab 
Annelene Dahl (Norway) – Shemesh/Mainen Lab 
António Dias (Portugal) - Lima Lab    
Cristina Ferreira (Portugal) - Vasconcelos Lab 
Gabriela Fioreze (Brazil) - Petreanu Lab    
Jovin Jacobs (Jamaica) - Carey Lab
Lorenza Calcaterra (Italy) - Kampff Lab

INDP ALUMNI 2012

INDP 2012

Asma Motiwala (India) - Paton & Machens Lab    
Nuno Loureiro (Portugal) - Costa Lab    
Nuno Calaim (Portugal) - Machens Lab    
Marina Fridman (USA) - Petreanu Lab    
Raphael Steinfeld (Germany) - Renart Lab    
Mert Erginkaya (Turkey) - Chiappe Lab    
Michael Pereira (Portugal) - Machens / Costa Lab
Hedi Young (UK) - Petreanu Lab    
Danbee Kim (USA) - Kampff Lab
Rita Felix (Portugal) - Carey Lab

INDP ALUMNI 2010

INDP 2010

Bruno Miranda (Portugal) - University College of London (Kennerley Lab) 
Carolina Doran (Portugal) - Bristol University (Franks Lab) 
Gonçalo Lopes (Portugal) - Kampff Lab    
Gustavo Mello (Brazil) - Paton Lab    
Ivo Marcelo (Portugal) -  Erasmus Rotterdam University
Simone Lackner (Austria) -  Orger Lab
Tiago Marques (Portugal) - Petreanu Lab    

INDP ALUMNI 2009

INDP 2009

Ali Argunsah (Turkey) - Israely Lab    
Andreia Cruz (Portugal) - Moita Lab    
Anna Hobbiss (UK) - Israely Lab    
David Raposo (Portugal) - CSHL (Churchland Lab)    
Diogo Peixoto (Portugal) - Stanford University (Newsome Lab)
Elizabeth Rickenbacher (USA/Switzerland) - Moita Lab    
Niccolò Bonacchi (Portugal/Italy) - Mainen Lab    
Pedro Garcia da Silva (Portugal) - CSHL (Albeanu Lab)
Raquel Abreu (Portugal) - UCLA (Feldman Lab)    
Sevinç Mutlu (Turkey) - Costa Lab

‘Metamersion: Latent Spaces’ joins art, science and technology at the Champalimaud Warehouse

The second edition of Metamersion, the cycle of artistic, scientific, technological and therapeutic immersive events of the Champalimaud Foundation, launches on December 15th with the programme Latent Spaces, taking place at the Champalimaud Warehouse, in the former warehouses of DocaPesca, in Lisbon, in a location that is also in a latent phase, and where the first steps towards the creation of a centre dedicated to Human Neuroecology and Digital Therapeutics are being taken.

Hands-on course on Zebrafish Xenografts 2023 - 2nd edition

This course is promoted by Champalimaud Foundation's Fior Lab, integrated in the congento - Consortium for Genetically Tractable Organisms - initiatives.

The scientific programme will cover

- Protocols for preparation of human cancer cells for injection;
- Generation of zebrafish xenografts (microinjection in the perivitelline space);
- Metastatic assay;
- Protocols for immunofluorescence;
- Mounting xenografts for confocal imaging;
- Confocal session.

Venue

Champalimaud Center for the Unknown, Lisbon

23 November 2022

Expert commission report pinpoints unprecedented challenges faced by cancer research in Europe

A report, published last week (16 November) in The Lancet Oncology by an expert commission, under the title Key messages from European Groundshot – addressing Europe’s cancer research challenges: a Lancet Oncology Commission, analyses the current state of cancer research in Europe, identifies geographical and gender gaps (among others), and issues recommendations to rethink the priorities of European cancer research.

Fátima Cardoso, director of the Breast Unit at the Champalimaud Clinical Center/Champalimaud Foundation, is among the co-authors of the new report.

17 November 2022

Check Up #9 - Markers of cancer

Cancers can be detected through the presence, in the tumours or bodily fluids, of so-called molecular biomarkers – in other words, of biological molecules (proteins, genes, etc.) found in blood or tissues that are a sign that a person has cancer. One well-known cancer biomarker is the PSA protein, whose rapid rise in the blood may indicate the presence of prostate cancer. 

10 November 2022

Portuguese consortium to receive 78 million euros funding from the Programa de Recuperação e Resiliência to develop “responsible” AI

For every argument that construes AI as essential, promising and transforming across nearly all industries, there are voiced concerns about this technology. Many people do not trust AI, claiming that intelligent machines will one day dominate humankind. But while this is a remote possibility, the harm that can be done to people (albeit mostly unintentionally) by deep learning algorithms is very tangible – and has already been known to occur in the real world.

Subscribe to Cancer
Loading
Please wait...